-
1
-
-
84928987900
-
HTSeq--a Python framework to work with high-throughput sequencing data
-
Anders S., Pyl P.T., Huber W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 2015, 31:166-169.
-
(2015)
Bioinformatics
, vol.31
, pp. 166-169
-
-
Anders, S.1
Pyl, P.T.2
Huber, W.3
-
2
-
-
79551649114
-
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
-
Badve S., Dabbs D.J., Schnitt S.J., Baehner F.L., Decker T., Eusebi V., Fox S.B., Ichihara S., Jacquemier J., Lakhani S.R., et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 2011, 24:157-167.
-
(2011)
Mod. Pathol.
, vol.24
, pp. 157-167
-
-
Badve, S.1
Dabbs, D.J.2
Schnitt, S.J.3
Baehner, F.L.4
Decker, T.5
Eusebi, V.6
Fox, S.B.7
Ichihara, S.8
Jacquemier, J.9
Lakhani, S.R.10
-
3
-
-
38949202980
-
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
-
Bergamaschi A., Tagliabue E., Sørlie T., Naume B., Triulzi T., Orlandi R., Russnes H.G., Nesland J.M., Tammi R., Auvinen P., et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 2008, 214:357-367.
-
(2008)
J. Pathol.
, vol.214
, pp. 357-367
-
-
Bergamaschi, A.1
Tagliabue, E.2
Sørlie, T.3
Naume, B.4
Triulzi, T.5
Orlandi, R.6
Russnes, H.G.7
Nesland, J.M.8
Tammi, R.9
Auvinen, P.10
-
4
-
-
0031905710
-
Fc receptors are required in passive and active immunity to melanoma
-
Clynes R., Takechi Y., Moroi Y., Houghton A., Ravetch J.V. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA 1998, 95:652-656.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 652-656
-
-
Clynes, R.1
Takechi, Y.2
Moroi, Y.3
Houghton, A.4
Ravetch, J.V.5
-
5
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
-
Clynes R.A., Towers T.L., Presta L.G., Ravetch J.V. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat. Med. 2000, 6:443-446.
-
(2000)
Nat. Med.
, vol.6
, pp. 443-446
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
6
-
-
69549131213
-
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
-
Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA 2009, 106:13820-13825.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 13820-13825
-
-
Creighton, C.J.1
Li, X.2
Landis, M.3
Dixon, J.M.4
Neumeister, V.M.5
Sjolund, A.6
Rimm, D.L.7
Wong, H.8
Rodriguez, A.9
Herschkowitz, J.I.10
-
7
-
-
84866784798
-
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy
-
DeNardo D.G., Brennan D.J., Rexhepaj E., Ruffell B., Shiao S.L., Madden S.F., Gallagher W.M., Wadhwani N., Keil S.D., Junaid S.A., et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011, 1:54-67.
-
(2011)
Cancer Discov.
, vol.1
, pp. 54-67
-
-
DeNardo, D.G.1
Brennan, D.J.2
Rexhepaj, E.3
Ruffell, B.4
Shiao, S.L.5
Madden, S.F.6
Gallagher, W.M.7
Wadhwani, N.8
Keil, S.D.9
Junaid, S.A.10
-
8
-
-
84871809302
-
STAR: ultrafast universal RNA-seq aligner
-
Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013, 29:15-21.
-
(2013)
Bioinformatics
, vol.29
, pp. 15-21
-
-
Dobin, A.1
Davis, C.A.2
Schlesinger, F.3
Drenkow, J.4
Zaleski, C.5
Jha, S.6
Batut, P.7
Chaisson, M.8
Gingeras, T.R.9
-
10
-
-
0028927709
-
Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages
-
Elomaa O., Kangas M., Sahlberg C., Tuukkanen J., Sormunen R., Liakka A., Thesleff I., Kraal G., Tryggvason K. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995, 80:603-609.
-
(1995)
Cell
, vol.80
, pp. 603-609
-
-
Elomaa, O.1
Kangas, M.2
Sahlberg, C.3
Tuukkanen, J.4
Sormunen, R.5
Liakka, A.6
Thesleff, I.7
Kraal, G.8
Tryggvason, K.9
-
11
-
-
84861708138
-
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways
-
Eroles P., Bosch A., Pérez-Fidalgo J.A., Lluch A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat. Rev. 2012, 38:698-707.
-
(2012)
Cancer Treat. Rev.
, vol.38
, pp. 698-707
-
-
Eroles, P.1
Bosch, A.2
Pérez-Fidalgo, J.A.3
Lluch, A.4
-
12
-
-
84901215262
-
The cellular and molecular origin of tumor-associated macrophages
-
Franklin R.A., Liao W., Sarkar A., Kim M.V., Bivona M.R., Liu K., Pamer E.G., Li M.O. The cellular and molecular origin of tumor-associated macrophages. Science 2014, 344:921-925.
-
(2014)
Science
, vol.344
, pp. 921-925
-
-
Franklin, R.A.1
Liao, W.2
Sarkar, A.3
Kim, M.V.4
Bivona, M.R.5
Liu, K.6
Pamer, E.G.7
Li, M.O.8
-
13
-
-
84866334922
-
TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation
-
Fuxe J., Karlsson M.C. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin. Cancer Biol. 2012, 22:455-461.
-
(2012)
Semin. Cancer Biol.
, vol.22
, pp. 455-461
-
-
Fuxe, J.1
Karlsson, M.C.2
-
14
-
-
13244256936
-
Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages
-
Gratchev A., Kzhyshkowska J., Utikal J., Goerdt S. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand. J. Immunol. 2005, 61:10-17.
-
(2005)
Scand. J. Immunol.
, vol.61
, pp. 10-17
-
-
Gratchev, A.1
Kzhyshkowska, J.2
Utikal, J.3
Goerdt, S.4
-
15
-
-
84903513963
-
Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads
-
Jiang H., Lei R., Ding S.W., Zhu S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinformatics 2014, 15:182.
-
(2014)
BMC Bioinformatics
, vol.15
, pp. 182
-
-
Jiang, H.1
Lei, R.2
Ding, S.W.3
Zhu, S.4
-
16
-
-
84860496687
-
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
-
Kaur P., Nagaraja G.M., Zheng H., Gizachew D., Galukande M., Krishnan S., Asea A. A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease. BMC Cancer 2012, 12:120.
-
(2012)
BMC Cancer
, vol.12
, pp. 120
-
-
Kaur, P.1
Nagaraja, G.M.2
Zheng, H.3
Gizachew, D.4
Galukande, M.5
Krishnan, S.6
Asea, A.7
-
17
-
-
84936147067
-
Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
-
Larkin J., Chiarion-Sileni V., Gonzalez R., Grob J.J., Cowey C.L., Lao C.D., Schadendorf D., Dummer R., Smylie M., Rutkowski P., et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 2015, 373:23-34.
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 23-34
-
-
Larkin, J.1
Chiarion-Sileni, V.2
Gonzalez, R.3
Grob, J.J.4
Cowey, C.L.5
Lao, C.D.6
Schadendorf, D.7
Dummer, R.8
Smylie, M.9
Rutkowski, P.10
-
18
-
-
0029947568
-
Enhancement of antitumor immunity by CTLA-4 blockade
-
Leach D.R., Krummel M.F., Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996, 271:1734-1736.
-
(1996)
Science
, vol.271
, pp. 1734-1736
-
-
Leach, D.R.1
Krummel, M.F.2
Allison, J.P.3
-
19
-
-
79961123152
-
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
-
Li B., Dewey C.N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011, 12:323.
-
(2011)
BMC Bioinformatics
, vol.12
, pp. 323
-
-
Li, B.1
Dewey, C.N.2
-
20
-
-
80051885494
-
Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies
-
Li F., Ravetch J.V. Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 2011, 333:1030-1034.
-
(2011)
Science
, vol.333
, pp. 1030-1034
-
-
Li, F.1
Ravetch, J.V.2
-
21
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
-
22
-
-
77953111817
-
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity
-
Matsushita N., Komine H., Grolleau-Julius A., Pilon-Thomas S., Mulé J.J. Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity. Cancer Immunol. Immunother. 2010, 59:875-884.
-
(2010)
Cancer Immunol. Immunother.
, vol.59
, pp. 875-884
-
-
Matsushita, N.1
Komine, H.2
Grolleau-Julius, A.3
Pilon-Thomas, S.4
Mulé, J.J.5
-
23
-
-
0028603343
-
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors
-
Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 1994, 127:2021-2036.
-
(1994)
J. Cell Biol.
, vol.127
, pp. 2021-2036
-
-
Miettinen, P.J.1
Ebner, R.2
Lopez, A.R.3
Derynck, R.4
-
24
-
-
0034256088
-
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity
-
Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R., Noonan D.M., Natali P.G., Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 2000, 87:336-342.
-
(2000)
Int. J. Cancer
, vol.87
, pp. 336-342
-
-
Morini, M.1
Mottolese, M.2
Ferrari, N.3
Ghiorzo, F.4
Buglioni, S.5
Mortarini, R.6
Noonan, D.M.7
Natali, P.G.8
Albini, A.9
-
25
-
-
56749174940
-
Exploring the full spectrum of macrophage activation
-
Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
-
(2008)
Nat. Rev. Immunol.
, vol.8
, pp. 958-969
-
-
Mosser, D.M.1
Edwards, J.P.2
-
26
-
-
58849101761
-
Activation of murine macrophages
-
Chapter 14. Unit 14.2
-
Mosser D.M., Zhang X. Activation of murine macrophages. Curr. Protoc. Immunol. 2008, Chapter 14. Unit 14.2.
-
(2008)
Curr. Protoc. Immunol.
-
-
Mosser, D.M.1
Zhang, X.2
-
27
-
-
77955038532
-
Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes
-
Movahedi K., Laoui D., Gysemans C., Baeten M., Stangé G., Van den Bossche J., Mack M., Pipeleers D., In't Veld P., De Baetselier P., Van Ginderachter J.A. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010, 70:5728-5739.
-
(2010)
Cancer Res.
, vol.70
, pp. 5728-5739
-
-
Movahedi, K.1
Laoui, D.2
Gysemans, C.3
Baeten, M.4
Stangé, G.5
Van den Bossche, J.6
Mack, M.7
Pipeleers, D.8
In't Veld, P.9
De Baetselier, P.10
Van Ginderachter, J.A.11
-
28
-
-
84904394690
-
Macrophage activation and polarization: nomenclature and experimental guidelines
-
Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20.
-
(2014)
Immunity
, vol.41
, pp. 14-20
-
-
Murray, P.J.1
Allen, J.E.2
Biswas, S.K.3
Fisher, E.A.4
Gilroy, D.W.5
Goerdt, S.6
Gordon, S.7
Hamilton, J.A.8
Ivashkiv, L.B.9
Lawrence, T.10
-
29
-
-
84904406680
-
Tumor-associated macrophages: from mechanisms to therapy
-
Noy R., Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014, 41:49-61.
-
(2014)
Immunity
, vol.41
, pp. 49-61
-
-
Noy, R.1
Pollard, J.W.2
-
30
-
-
62449131093
-
Supervised risk predictor of breast cancer based on intrinsic subtypes
-
Parker J.S., Mullins M., Cheang M.C., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 2009, 27:1160-1167.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 1160-1167
-
-
Parker, J.S.1
Mullins, M.2
Cheang, M.C.3
Leung, S.4
Voduc, D.5
Vickery, T.6
Davies, S.7
Fauron, C.8
He, X.9
Hu, Z.10
-
31
-
-
84887481716
-
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
-
Pyonteck S.M., Akkari L., Schuhmacher A.J., Bowman R.L., Sevenich L., Quail D.F., Olson O.C., Quick M.L., Huse J.T., Teijeiro V., et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 2013, 19:1264-1272.
-
(2013)
Nat. Med.
, vol.19
, pp. 1264-1272
-
-
Pyonteck, S.M.1
Akkari, L.2
Schuhmacher, A.J.3
Bowman, R.L.4
Sevenich, L.5
Quail, D.F.6
Olson, O.C.7
Quick, M.L.8
Huse, J.T.9
Teijeiro, V.10
-
32
-
-
77950950894
-
Macrophage diversity enhances tumor progression and metastasis
-
Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
-
(2010)
Cell
, vol.141
, pp. 39-51
-
-
Qian, B.Z.1
Pollard, J.W.2
-
33
-
-
77953176036
-
A scaling normalization method for differential expression analysis of RNA-seq data
-
Robinson M.D., Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010, 11:R25.
-
(2010)
Genome Biol.
, vol.11
, pp. R25
-
-
Robinson, M.D.1
Oshlack, A.2
-
34
-
-
75249087100
-
EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data
-
Robinson M.D., McCarthy D.J., Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140.
-
(2010)
Bioinformatics
, vol.26
, pp. 139-140
-
-
Robinson, M.D.1
McCarthy, D.J.2
Smyth, G.K.3
-
35
-
-
84928774156
-
The future of immune checkpoint therapy
-
Sharma P., Allison J.P. The future of immune checkpoint therapy. Science 2015, 348:56-61.
-
(2015)
Science
, vol.348
, pp. 56-61
-
-
Sharma, P.1
Allison, J.P.2
-
36
-
-
48349102876
-
Macrophage polarization in tumour progression
-
Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M.G., Rimoldi M., Biswas S.K., Allavena P., Mantovani A. Macrophage polarization in tumour progression. Semin. Cancer Biol. 2008, 18:349-355.
-
(2008)
Semin. Cancer Biol.
, vol.18
, pp. 349-355
-
-
Sica, A.1
Larghi, P.2
Mancino, A.3
Rubino, L.4
Porta, C.5
Totaro, M.G.6
Rimoldi, M.7
Biswas, S.K.8
Allavena, P.9
Mantovani, A.10
-
37
-
-
84884271914
-
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
-
Simpson T.R., Li F., Montalvo-Ortiz W., Sepulveda M.A., Bergerhoff K., Arce F., Roddie C., Henry J.Y., Yagita H., Wolchok J.D., et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J. Exp. Med. 2013, 210:1695-1710.
-
(2013)
J. Exp. Med.
, vol.210
, pp. 1695-1710
-
-
Simpson, T.R.1
Li, F.2
Montalvo-Ortiz, W.3
Sepulveda, M.A.4
Bergerhoff, K.5
Arce, F.6
Roddie, C.7
Henry, J.Y.8
Yagita, H.9
Wolchok, J.D.10
-
38
-
-
34249300128
-
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
-
Sinha P., Clements V.K., Fulton A.M., Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 2007, 67:4507-4513.
-
(2007)
Cancer Res.
, vol.67
, pp. 4507-4513
-
-
Sinha, P.1
Clements, V.K.2
Fulton, A.M.3
Ostrand-Rosenberg, S.4
-
39
-
-
84859991126
-
Mouse model recapitulating human Fcγ receptor structural and functional diversity
-
Smith P., DiLillo D.J., Bournazos S., Li F., Ravetch J.V. Mouse model recapitulating human Fcγ receptor structural and functional diversity. Proc. Natl. Acad. Sci. USA 2012, 109:6181-6186.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 6181-6186
-
-
Smith, P.1
DiLillo, D.J.2
Bournazos, S.3
Li, F.4
Ravetch, J.V.5
-
40
-
-
84902959977
-
Myeloid-derived suppressor cell heterogeneity in human cancers
-
Solito S., Marigo I., Pinton L., Damuzzo V., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann. N Y Acad. Sci. 2014, 1319:47-65.
-
(2014)
Ann. N Y Acad. Sci.
, vol.1319
, pp. 47-65
-
-
Solito, S.1
Marigo, I.2
Pinton, L.3
Damuzzo, V.4
Mandruzzato, S.5
Bronte, V.6
-
41
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98:10869-10874.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 10869-10874
-
-
Sørlie, T.1
Perou, C.M.2
Tibshirani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
Hastie, T.7
Eisen, M.B.8
van de Rijn, M.9
Jeffrey, S.S.10
-
42
-
-
84894520967
-
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells
-
e26968
-
Strachan D.C., Ruffell B., Oei Y., Bissell M.J., Coussens L.M., Pryer N., Daniel D. CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells. OncoImmunology 2013, 2:e26968.
-
(2013)
OncoImmunology
, vol.2
-
-
Strachan, D.C.1
Ruffell, B.2
Oei, Y.3
Bissell, M.J.4
Coussens, L.M.5
Pryer, N.6
Daniel, D.7
-
43
-
-
0028042424
-
FcR gamma chain deletion results in pleiotrophic effector cell defects
-
Takai T., Li M., Sylvestre D., Clynes R., Ravetch J.V. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994, 76:519-529.
-
(1994)
Cell
, vol.76
, pp. 519-529
-
-
Takai, T.1
Li, M.2
Sylvestre, D.3
Clynes, R.4
Ravetch, J.V.5
-
44
-
-
48549100414
-
Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
-
Taylor R.P., Lindorfer M.A. Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies. Curr. Opin. Immunol. 2008, 20:444-449.
-
(2008)
Curr. Opin. Immunol.
, vol.20
, pp. 444-449
-
-
Taylor, R.P.1
Lindorfer, M.A.2
-
45
-
-
0021824999
-
Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody
-
Thomson T.M., Mattes M.J., Roux L., Old L.J., Lloyd K.O. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J. Invest. Dermatol. 1985, 85:169-174.
-
(1985)
J. Invest. Dermatol.
, vol.85
, pp. 169-174
-
-
Thomson, T.M.1
Mattes, M.J.2
Roux, L.3
Old, L.J.4
Lloyd, K.O.5
-
46
-
-
84926525215
-
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
-
Twyman-Saint Victor C., Rech A.J., Maity A., Rengan R., Pauken K.E., Stelekati E., Benci J.L., Xu B., Dada H., Odorizzi P.M., et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 2015, 520:373-377.
-
(2015)
Nature
, vol.520
, pp. 373-377
-
-
Twyman-Saint Victor, C.1
Rech, A.J.2
Maity, A.3
Rengan, R.4
Pauken, K.E.5
Stelekati, E.6
Benci, J.L.7
Xu, B.8
Dada, H.9
Odorizzi, P.M.10
-
47
-
-
59449090107
-
TGF-beta-induced epithelial to mesenchymal transition
-
Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
-
(2009)
Cell Res.
, vol.19
, pp. 156-172
-
-
Xu, J.1
Lamouille, S.2
Derynck, R.3
|